Question 1

What is OMIDENEPAG ISOPROPYL used for?

Accepted Answer

OMIDENEPAG ISOPROPYL (brand name Omlonti) is a Other indicated for 1 INDICATIONS AND USAGE Omlonti (omidenepag isopropyl ophthalmic solution) 0.002%, is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Omlonti (omidenepag isopropyl ophthalmic solution) 0.002%, is a relatively selective prostaglandin E2 (EP2) receptor agonist.

Question 2

How does OMIDENEPAG ISOPROPYL work?

Accepted Answer

OMIDENEPAG ISOPROPYL works through the following mechanism: 12.1 Mechanism of Action Omidenepag is a relatively selective EP2 receptor agonist which decreases intraocular pressure (IOP). The exact mechanism of action is unknown at this time. Elevated IOP represents a major risk factor for glaucomatous field loss. The higher the level of IOP, the greater the likelihood of optic nerve damage and visual field loss..

Question 3

What are the most common side effects of OMIDENEPAG ISOPROPYL?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for OMIDENEPAG ISOPROPYL. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is OMIDENEPAG ISOPROPYL the same as Omlonti?

Accepted Answer

Omlonti is a brand name for OMIDENEPAG ISOPROPYL. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

OMIDENEPAG ISOPROPYL

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations